Understanding the genetic causes of 22q11.2 deletion syndrome using zebrafish models

Mechanistic dissection of 22q11.2DS in zebrafish

NIH-funded research Boston Children's Hospital · NIH-11000284

This study is looking at how changes in a specific gene can affect the health and development of children with 22q11.2 deletion syndrome, using zebrafish to help understand how these changes might lead to heart and facial problems, with the goal of finding new ways to help kids with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11000284 on NIH RePORTER

What this research studies

This research investigates the genetic mechanisms behind 22q11.2 deletion syndrome, a condition that can lead to serious health issues in children, including heart defects and facial abnormalities. By using zebrafish as a model organism, researchers aim to understand how specific genetic deletions affect the development of critical structures in the body. The study focuses on the role of the TBX1 gene and its impact on craniofacial and cardiovascular development. Through this work, the researchers hope to identify potential targets for therapeutic interventions that could improve outcomes for affected children.

Who could benefit from this research

Good fit: Ideal candidates for this research are children under 11 years old diagnosed with 22q11.2 deletion syndrome or related conditions.

Not a fit: Patients who do not have 22q11.2 deletion syndrome or similar genetic conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for children with 22q11.2 deletion syndrome.

How similar studies have performed: Previous research using zebrafish models has shown promise in understanding genetic syndromes, indicating that this approach may yield valuable insights.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions 22q11 Chromosomal Microdeletion Syndrome22q11 Deletion Syndrome22q11.2 deletion syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.